PROGNOSTIC ROLE OF PATHOLOGICAL CHEMOTHERAPY RESPONSE SCORE IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER

被引:0
|
作者
Setton, Ariella Jakobson [1 ,2 ]
Levin, Gabriel [3 ]
Raban, Oded [1 ,2 ]
Sabah, Gad [1 ,2 ]
Tsoref, Daliah [4 ]
From, Anat [1 ,5 ]
Perri, Tamar [3 ]
Eitan, Ram [5 ]
机构
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Obstet & Gynecol, Tel Aviv, Israel
[3] Hadassah Univ Hosp, Obstet & Gynecol, Jerusalem, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Dept Oncol, Rabin Med Ctr Petah Tikva, Tel Aviv, Israel
[5] Tel Aviv Univ, Dept Obstet & Gynecol, Sackler Fac Med, Tel Aviv, Israel
关键词
D O I
10.1136/ijgc-2022-igcs.319
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP228/#913
引用
收藏
页码:A142 / A143
页数:2
相关论文
共 50 条
  • [1] Prognostic Value of Pathologic Chemotherapy Response Score in Patients With Ovarian Cancer After Neoadjuvant Chemotherapy
    Michaan, Nadav
    Chong, Woo Yoo
    Han, Na Young
    Lim, Myong Cheol
    Park, Sang Yoon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (09) : 1676 - 1682
  • [2] The prognostic significance of chemotherapy response score and lymphocytic infiltration in patients with ovarian cancer treated with neoadjuvant chemotherapy
    Rodolakis, J.
    Prodromidou, A.
    Thomakos, N.
    Sotiropoulou, M.
    Liontos, M.
    Haidopoulos, D.
    Rodolakis, A.
    Loutradis, D.
    Bamias, A.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2022, 270 : E34 - E34
  • [3] The prognostic value of chemotherapy response score and lymphocytic infiltration ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Sotiropoulou, M.
    Kaparelou, M.
    Tzannis, K.
    Tsironis, G.
    Kyriazoglou, A.
    Tsiara, A.
    Zakopoulou, R.
    Rodolakis, I.
    Koutsoukos, K.
    Zagouri, F.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Bamias, A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 83 - 84
  • [4] Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy
    Liontos, Michalis
    Sotiropoulou, Maria
    Kaparelou, Maria
    Tzannis, Kimon
    Tsironis, George
    Kyriazoglou, Anastasios
    Tsiara, Anna
    Zakopoulou, Roubini
    Koutsoukos, Konstantinos
    Zagouri, Flora
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Rodolakis, Alexandros
    Dimopoulos, Meletios A.
    Bamias, Aristotelis
    GYNECOLOGIC ONCOLOGY, 2020, 157 (03) : 599 - 605
  • [5] PATHOLOGICAL CHEMOTHERAPY RESPONSE SCORE PREDICTS SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN CANCER RECEIVING NEOADJUVANT CHEMOTHERAPY: AN INDIVIDUAL PATIENT META-ANALYSIS
    Cohen, P.
    Bohm, S.
    Powell, A.
    Meniawy, T. M.
    Stewart, C. J. R.
    Bulsara, M.
    Gilks, C. B.
    Singh, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 14 - 14
  • [6] Pathological response of ovarian cancer to neoadjuvant chemotherapy
    Ivantsov, Alexandr O.
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
  • [7] Evaluation of chemotherapy response score and lymphocytic infiltration as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Sotiropoulou, M.
    Kaparelou, M.
    Tzannis, K.
    Tsironis, G.
    Kyriazoglou, A.
    Tsiara, A.
    Zakopoulou, R.
    Koutsoukos, K.
    Zagouri, F.
    Vlachos, D.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Dimopoulos, M. A. C.
    Bamias, A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] Pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
    Montemurro, Filippo
    Di Cosimo, Serena
    BREAST, 2014, 23 (05): : 690 - 691
  • [9] Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    M. Liontos
    A. Andrikopoulou
    K. Koutsoukos
    C. Markellos
    E. Skafida
    O. Fiste
    M. Kaparelou
    N. Thomakos
    D. Haidopoulos
    A. Rodolakis
    M. A. Dimopoulos
    F. Zagouri
    Journal of Ovarian Research, 14
  • [10] Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
    Liontos, M.
    Andrikopoulou, A.
    Koutsoukos, K.
    Markellos, C.
    Skafida, E.
    Fiste, O.
    Kaparelou, M.
    Thomakos, N.
    Haidopoulos, D.
    Rodolakis, A.
    Dimopoulos, M. A.
    Zagouri, F.
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)